Table 1.
Clinical characteristics comparing patients with and without all-cause mortality endpoint during the median of 5.3 years follow-up.
| Survival n = 381 (87%) |
Death n = 59 (13%) |
p-Value | |
|---|---|---|---|
| Demographic data | |||
| Gender, male n (%) | 332 (87%) | 50 (85%) | 0.8827 |
| Age, years (mean ± SD) | 64.1 ± 7.9 | 66.6 ± 8 | 0.0351 |
| BMI, kg/m2 (mean ± SD) | 28.5 ± 3.6 | 28.8 ± 4.2 | 0.4593 |
| BSA, m2 (mean ± SD) | 1.9 ± 0.2 | 1.9 ± 0.2 | 0.9404 |
| Clinical data | |||
| Left main disease n (%) | 83 (22%) | 18 (31%) | 0.1276 |
| Arterial hypertension n (%) | 290 (76%) | 49 (83%) | 0.2349 |
| DM n (%) | 128 (34%) | 22 (37%) | 0.6517 |
| Hypercholesterolemia n (%) | 218 (57%) | 24 (41%) | 0.3829 |
| COPD n (%) | 34 (9%) | 10 (17%) | <0.0001 |
| Stroke n (%) | 29 (8%) | 10 (17%) | 0.0261 |
| PAD n (%) | 53 (14%) | 14 (24%) | 0.0473 |
| Chronic kidney disease n (%) | 25 (7%) | 8 (14%) | 0.0642 |
| Pre-operative laboratory parameters | |||
| WBC, ×109/L (mean ± SD) | 8.0 ± 2.9 | 8.1 ± 2.0 | 0.4125 |
| Neutrophils, ×109/L (mean ± SD) | 5.2 ± 2.3 | 5.6 ± 1.9 | 0.0715 |
| Hb, mmol/L (mean ± SD) | 8.7 ± 1.1 | 8.6 ± 0.9 | 0.1747 |
| Plt ×109/L (mean ± SD) | 232.8 ± 63.0 | 239.1 ± 71.7 | 0.5670 |
| NLR (mean ± SD) | 3.2 ± 2.8 | 3.7 ± 3.6 | 0.0256 |
| Pre-operative echocardiographic parameters | |||
| LVEDD, mm (mean ± SD) | 49 ± 6 | 51 ± 7 | 0.0049 |
| LVEF, (mean ± SD) | 54 ± 9 | 49 ± 11 | 0.0012 |
| Intraoperative data | |||
| Surgery time, h (mean ± SD) | 2:39 ± 0:3 | 2:36 ± 0:4 | 0.4965 |
| Anastomoses, number (mean ± SD) | 2.3 ± 0.2 | 2.2 ± 0.2 | 0.0746 |
| Blood product transfusion n (%) | 151 (40%) | 27 (46%) | 0.3829 |
| Length of stay, days (mean ± SD) | 8 ± 3 | 8 ± 2 | 1.0000 |
| Post-operative laboratory parameters | |||
| WBC, ×109/L (mean ± SD) | 8.9 ± 3.2 | 9.1 ± 3.2 | 0.7186 |
| Neutrophils, ×109/L (mean ± SD) | 5.4 ± 2.4 | 6 ± 2.9 | 0.2165 |
| Hb, mmol/L (mean ± SD) | 6.9 ± 0.8 | 7 ± 0.8 | 0.9804 |
| Plt ×109/L (mean ± SD) | 287.1 ± 106.9 | 283.4 ± 98.2 | 0.5843 |
| NLR (mean ± SD) | 3.0 ± 1.9 | 3.8 ± 3.2 | 0.0173 |
| Injury markers: | |||
| Troponin T, ng/mL (mean ± SD) | 4.33 ± 14.2 | 3.66 ± 5.9 | 0.3726 |
| CK-MB mass, ng/mL (mean ± SD) | 18.7 ± 33.4 | 19.3 ± 28.9 | 0.5293 |
| Post-operative echocardiographic parameters | |||
| LVEDD, mm (mean ± SD) | 48 ± 7 | 51 ± 7 | 0.0017 |
| LVEF, (mean ± SD) | 55 ± 9 | 49 ± 11 | 0.0010 |
Abbreviations: BMI—body mass index, BSA—body surface area, COPD—chronic obstructive pulmonary disease, CK-MB—creatine kinase myocardial band, DM—diabetes mellitus, Hb—hemoglobin, LVEDD—left ventricle end-diastolic diameter, LVEF—left ventricle ejection fraction, NLR—neutrophil-to-lymphocyte ratio, PAD—peripheral artery disease, Plt—platelets, WBC—white blood count.